Barbara Zdrazil
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Correction: Integrating artificial intelligence and manual curation to enhance bioassay annotations in ChEMBL.
Journal: Journal of cheminformatics
Published: March 28, 2026
Correction to "Pseudonatural Products for Chemical Biology and Drug Discovery".
Journal: Journal of medicinal chemistry
Published: October 21, 2025
A genomic-led strategy to anticipate drug safety effects.
Journal: PLoS genetics
Published: September 30, 2025
Drug and Clinical Candidate Drug Data in ChEMBL.
Journal: Journal of medicinal chemistry
Published: September 19, 2025
ChEBI: re-engineered for a sustainable future.
Journal: Nucleic acids research
Published: September 18, 2025
EMBL's European Bioinformatics Institute (EMBL-EBI) in 2025.
Journal: Nucleic acids research
Published: September 15, 2025
Integrating artificial intelligence and manual curation to enhance bioassay annotations in ChEMBL.
Journal: Journal of cheminformatics
Published: September 05, 2025
Pseudonatural Products for Chemical Biology and Drug Discovery.
Journal: Journal of medicinal chemistry
Published: July 01, 2025
Natural language processing in drug discovery: bridging the gap between text and therapeutics with artificial intelligence.
Journal: Expert opinion on drug discovery
Published: April 29, 2025
Leveraging large-scale biobanks for therapeutic target discovery.
Journal: HGG advances
Published: April 17, 2025
Fifteen years of ChEMBL and its role in cheminformatics and drug discovery.
Journal: Journal of cheminformatics
Published: December 21, 2024
EMBL's European Bioinformatics Institute (EMBL-EBI) in 2024.
Journal: Nucleic acids research
Published: September 13, 2024
Last Updated: 09/26/2026